YoVDO

Quantifying CAR T Cells Activity Against AML - Model Selection Based on In Vitro Cytolytic Assays

Offered By: Mathematical Oncology via YouTube

Tags

Mathematical Oncology Courses Systems Biology Courses Cancer Treatment Courses Computational Modeling Courses Model Selection Courses Immunotherapy Courses CAR T-cell Therapy Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore a comprehensive seminar on quantifying CAR T cell activity against Acute Myeloid Leukemia (AML) through model selection based on in vitro cytolytic assays. Presented by Dr. Philipp Altrock as part of the Mathematical Oncology seminar series, this 1-hour and 13-minute talk delves into the cutting-edge research in immunotherapy for AML treatment. Gain insights into the mathematical modeling approaches used to evaluate the effectiveness of CAR T cells in targeting AML cells, and understand the importance of in vitro cytolytic assays in this process. Learn about the latest advancements in CAR T cell therapy and its potential impact on AML treatment strategies. This seminar is ideal for researchers, oncologists, and students interested in the intersection of immunotherapy, mathematical modeling, and cancer treatment.

Syllabus

Dr. Philipp Altrock - Quantifying CAR T cells activity against AML


Taught by

Mathematical Oncology

Related Courses

Advancements in the Treatment of Blood Cancers - Closer to a Cure Series
University of California, Los Angeles via YouTube CAR T-Cell Therapy for Pediatric Cancer - Satiro de Oliveira, MD - UCLAMDChat
University of California, Los Angeles via YouTube CAR T at UCLA - Driving the Progress of Engineered Cell Therapy
University of California, Los Angeles via YouTube A Living Drug That Could Change the Way We Treat Cancer
TED via YouTube CRISPR - Cas9 Gene Therapy and CAR T-Cell Therapy - Promising?
Medicosis Perfectionalis via YouTube